Forex

Royal Bank of Canada Invests Heavily in Intellia Therapeutics

Guavy AI Editorial Team Published August 12, 2026

Instruments

CAD

Royal Bank of Canada acquired a significant stake in Intellia Therapeutics, increasing its holdings by 1,082.1% in the first quarter.

The bank owned 465,499 shares after purchasing an additional 426,121 shares during the period.

This investment makes Royal Bank of Canada the second-largest shareholder of Intellia Therapeutics, with a 0.33% stake in the company worth $5,968,000 as of its most recent filing with the SEC.

European Stocks Slump on Rising Oil Prices Amid US Inflation Relief

Forex 1m ago

Netherlands Inflation Hits 3.2% as Fuel Prices Surge

Forex 1m ago

Tech Shares Surge as US Inflation Data Eases Rate Hike Fears

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

Terms Privacy Policy